BLI 1100

Drug Profile

BLI 1100

Alternative Names: BLI1100

Latest Information Update: 07 Aug 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Braintree Laboratories
  • Class Antiacnes
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Phase II Acne vulgaris

Most Recent Events

  • 01 Jun 2016 Braintree Laboratories completes a phase II trial in Acne vulgaris (In adolescents, In adults) in USA (Topical, Gel) (NCT02604680)
  • 01 Oct 2015 Phase-II clinical trials in Acne vulgaris (In adolescents, In adults) in USA (Topical, Gel) (NCT02604680)
  • 27 Aug 2015 No recent reports on development identified - Phase-II for Acne vulgaris in USA (Topical, Cream)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top